Angelini Ventures
Overview
Angelini Ventures, the venture capital arm of Angelini Industries, is a Series A and Series B investment firm focused on accelerating disruptive innovations and trends in BioTech and Digital Health. Angelini Ventures will invest €300 million across a global portfolio in Europe and North America, drawing on a global team, strategic advisors and partners to help entrepreneurs scale their businesses into transformative category-leading companies. The firm focuses on leveraging technology to improve healthcare, reshape patient journeys, and address unmet needs in vulnerable populations.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Epicrispr Biotechnologies | Aug 2026 | Series C | Co-investor |
| Neumirna Therapeutics | Jan 2025 | Series A | Lead |
| Argobio | Mar 2021 | VC Round | Co-investor |
| Hypervision Surgical | Apr 2026 | Series A | Co-investor |
| Therini Bio | May 2025 | Series A Extension | Lead |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Angelini Ventures based?
Angelini Ventures is headquartered in Italy.
When was Angelini Ventures founded?
Angelini Ventures was founded in 2021.
How many portfolio companies does Angelini Ventures have?
Angelini Ventures has 29 portfolio companies in Caplight's dataset.
What are some companies in Angelini Ventures's portfolio?
Portfolio companies visible on Caplight include Epicrispr Biotechnologies, Neumirna Therapeutics, Argobio, Hypervision Surgical, Therini Bio.
What was Angelini Ventures's most recent investment shown here?
Angelini Ventures's most recent investment in this portfolio sample was in Epicrispr Biotechnologies in 2026.
What sectors does Angelini Ventures focus on?
Angelini Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Enterprise Software, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Enterprise Software, Frontier & Industrial Tech.
What company stages does Angelini Ventures focus on?
Angelini Ventures typically invests at the Early stage.
What is Angelini Ventures's AUM?
Angelini Ventures's assets under management are estimated between $250.0M and $500.0M.